Implantable Port Developing Septic Pulmonary Emboli and Secondary Spontaneous Pneumothorax

Rohan Madhu Prasad^1, , Fazal Raziq¹, Tyler Kemnic¹ and Ahmed Abubaker²

¹Department of Internal Medicine, Michigan State University - Sparrow Hospital, Lansing, Michigan, United States

²Department of Infectious Disease, Michigan State University - Sparrow Hospital, Lansing, Michigan, United State

Cite this paper

Rohan Madhu Prasad, Fazal Raziq, Tyler Kemnic and Ahmed Abubaker. Implantable Port Developing Septic Pulmonary Emboli and Secondary Spontaneous Pneumothorax. American Journal of Medical Case Reports. 2021; 9(1):35-39. doi: 10.12691/AJMCR-9-1-10

Abstract

This case report illustrates the rare occurrence of an implantable port becoming infected, forming septic pulmonary emboli (SPE), and eventually a secondary spontaneous pneumothorax (SSP). A 43-year-old male presented to the emergency department for a five-day duration of fevers, generalized malaise, difficulty in breathing, non-productive cough, and left chest pain. Past history revealed right carotid body paraganglioma that required resection, adjuvant chemotherapy via a port in the left subclavian vein, and radiation. The cancer was in remission for one year prior to this admission and the port had not been used in six months, but had not been removed. Chest computed tomography demonstrated bilateral pleural cavitations and parenchymal ground-glass opacities. Blood cultures and subsequent sensitivities grew methicillin sensitive Staphylococcus aureus (MSSA). We initiated empiric broad spectrum coverage and later switched to cefazolin. A left shoulder ultrasound illustrated a subclavian vein thrombus, so the port was removed. Culture of the catheter tip also grew MSSA. Four days later the patient developed acute dyspnea. Repeat imaging showed a new right-sided spontaneous hydropneumothorax with loculated pleural effusions along with progression of the bilateral opacities and cavitations. Therefore, chest tubes were placed with pleural fluid cultures growing MSSA. Additionally, video-assisted thoracoscopic surgery with decortication was performed. The patient was discharged home on six weeks of intravenous cefazolin via a peripherally inserted central catheter (PICC). This case demonstrates that the physicians should be aware of the lethal complications of a port and should attempt to remove them once they are no longer required.

Keywords

case report, implantable port, central venous access, methicillin sensitive staphylococcus aureus, septic pulmonary emboli, secondary spontaneous pneumothorax

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Parkar AP, Kandiah P. Differential diagnosis of cavitary lung lesions. J Belg Soc Radiol. 2016; 100(1): 100.
[2]	Hong G, Kim YS. Recurrent septic pulmonary embolism related to an implanted central venous access port device. Chinese Medical Journal. 2018; 131(24): 3009-3011.
[3]	Okabe M, Kasai K, Yokoo T. Pneumothorax secondary to septic pulmonary emboli in a long-term hemodialysis patient with psoas abscess. Nihon Naika Gakkai. 2017; 56: 3243-3247.
[4]	O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases. 2011; 52: e162-e193.
[5]	Didi M, Mejri N, Labidi S, et al. Implantable port thrombosis in cancer patients: a monocentric experience. Cancer Biol Med. 2016; 13(3): 384-388.
[6]	Okada H, Taira K, Tokunaga S, et al. A case of a septic pulmonary embolism related implanted central venous port. Gan To Kagaku Ryoho. 2013; 40(3): 389-392.
[7]	Gibson CD, Shah P, Jean RA, Jean RE. Prevalence and predictors of pneumothorax in patients with septic pulmonary embolism Am J Respir Crit Care Med. 2017; 195: A3948.
[8]	Riley DS, Barber MS, Kienle GS, et al. CARE 2013 Explanation and elaborations: reporting guidelines for case reports JClinEpi. 2017; 89: 218-235.
[9]	Galloway S, Bodenham A. Long-term central venous access. British Journal of Anesthesia. 2004; 92(5): 722-734.
[10]	Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clinical Infectious Diseases. 2001; 32: 1249-1272.
[11]	Santarpia L, Buonomo A, Pagano MC, et al. Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome. Clin Nutr ESPEN. 2016; 35: 1394-1398.
[12]	Crowley AL, Peterson GE, Benjamin Jr DK, et al. Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Critical Care Medicine. 2008; 36(2): 385-390.
[13]	Baskin JL, Pui CH, Reiss U, et al. Management of occlusion and thrombosis associated with long term indwelling central venous catheters. Lancet. 2009; 374(9648): 159.
[14]	Cook RJ, Aston RW, Aughenbaugh GL, Ryu JH. Septic pulmonary embolism: Presenting features and clinical course of 14 Patients. CHEST. 2005; 128(1): 162-166.
[15]	Lee SJ, Cha SI, Kim CH, et al. Septic pulmonary embolism in Korea: Microbiology, clinicoradiologic features, and treatment outcome. Journal of Infection. 2007; 54: 2230-234.
[16]	Inamoto S, Hashimoto Y. A Case of pneumothorax secondary to septic pulmonary embolism due to central venous catheter infection caused by methicillin-resistant Staphylococcus aureus. Nihon Kansensho Gakkai. 2008; 82(1): 51-54.
[17]	Yang SF, Yang WC, Lin CC. Infective endocarditis-related bilateral spontaneous pneumothorax in a hemodialysis patient. Acta Clinica Belgica. 2011; 61(1): 51.
[18]	Schnell J, Koryllos A, Lopez-Pastorini A, Lefering R, Stoelben E. Spontaneous pneumothorax - epidemiology and treatment in Germany between 2011 and 2015. Deutsches Arzteblatt International. 2017; 114: 739-744.